Status:
COMPLETED
Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients
Lead Sponsor:
Pfizer
Conditions:
Tuberculosis
Non-tuberculous Mycobacterial Diseases (Including MAC Disease)
Eligibility:
All Genders
Brief Summary
The objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in thi...
Detailed Description
All the patients whom an investigator prescribes the first Mycobutin® should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into t...
Eligibility Criteria
Inclusion
- Patients need to be administered Mycobutin® in order to be enrolled in the surveillance.
Exclusion
- Patients not administered Mycobutin®.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
628 Patients enrolled
Trial Details
Trial ID
NCT00810407
Start Date
November 1 2008
End Date
July 1 2016
Last Update
March 7 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.